Nerviano Medical Sciences
Clinical trials sponsored by Nerviano Medical Sciences, explained in plain language.
-
New hope for recurrent ovarian cancer? early trial combines novel PARP inhibitor with chemo
Disease control Recruiting nowThis early-stage study tests a new experimental drug (NMS-03305293) combined with a standard chemotherapy (topotecan) in about 24 people whose ovarian cancer has returned after previous treatments. The main goals are to check safety and find the best dose, while also seeing if th…
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New hope for tough lung cancer? early trial tests novel drug combo
Disease control Recruiting nowThis early-stage trial is testing a new oral drug called NMS-03305293, combined with the chemotherapy temozolomide, in 10 people with relapsed small cell lung cancer. The main goal is to check safety and tolerability, while also looking for signs that the tumors shrink. All parti…
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for tough leukemia: experimental drug targets resistant cancers
Disease control Recruiting nowThis study tests a new drug, NMS-03597812, in adults with acute myeloid leukemia that has come back or not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink or control the cancer. About 124 people will take part, including those with…
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC